Vita, Emanuele
 Distribuzione geografica
Continente #
EU - Europa 246
NA - Nord America 228
AS - Asia 127
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 608
Nazione #
US - Stati Uniti d'America 222
IT - Italia 82
SG - Singapore 69
SE - Svezia 61
CN - Cina 29
DE - Germania 25
ID - Indonesia 16
IE - Irlanda 16
FI - Finlandia 14
RU - Federazione Russa 11
FR - Francia 10
CZ - Repubblica Ceca 9
CA - Canada 4
CI - Costa d'Avorio 4
ES - Italia 4
GB - Regno Unito 4
IN - India 4
TR - Turchia 4
BE - Belgio 3
DO - Repubblica Dominicana 2
IR - Iran 2
KR - Corea 2
LT - Lituania 2
NL - Olanda 2
CH - Svizzera 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 608
Città #
Singapore 57
Chandler 56
Ashburn 37
Rome 25
Cattolica 16
Dublin 16
Jakarta 16
New York 16
Boardman 14
Milan 14
Helsinki 11
Brno 9
Moscow 8
San Mateo 7
Bremen 6
Princeton 6
Boston 5
Frankfurt am Main 5
Marseille 5
Abidjan 4
Beijing 4
Falkenstein 4
Madrid 4
Brussels 3
Lappeenranta 3
Los Angeles 3
Paris 3
Starnberg 3
Wilmington 3
Busto Arsizio 2
Fairfield 2
Isorella 2
Kocaeli 2
London 2
Munich 2
New Haven 2
Nuremberg 2
Ottawa 2
San Rafael 2
Santo Domingo 2
Seattle 2
Seoul 2
Toronto 2
Venice 2
Verdellino 2
Anzio 1
Arezzo 1
Auckland 1
Cervignano del Friuli 1
Chicago 1
Cologne 1
Dalian 1
Durban 1
Hong Kong 1
Irving 1
Jiaxing 1
Kish 1
Leawood 1
Liberty Lake 1
Luoyang 1
Neuilly-sur-Marne 1
Norwalk 1
Nuoro 1
Palermo 1
Piraeus 1
Santa Clara 1
Tianjin 1
Vikrampur 1
Vilnius 1
Woodbridge 1
Xiamen 1
Zhengzhou 1
Zurich 1
Totale 423
Nome #
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 75
From palliation to cure: PIPAC for peritoneal malignancies 66
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 56
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 53
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 51
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 49
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 48
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 31
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 30
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 28
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 25
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 24
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 24
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 22
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 21
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 15
Surgery after induction chemo or immunotherapy for locally advanced NSCLC 13
Totale 631
Categoria #
all - tutte 4.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 1 0
2020/202116 0 0 0 0 0 0 0 0 1 4 10 1
2021/202272 20 0 1 14 1 1 0 8 2 2 8 15
2022/2023157 21 20 13 27 9 23 11 8 18 0 2 5
2023/2024203 3 35 9 10 8 18 26 9 2 21 21 41
2024/2025176 23 6 41 34 42 30 0 0 0 0 0 0
Totale 631